Consumer Groups Say Aneurysm Fixer Needs More FDA Tests

By Keith Goldberg (February 29, 2012, 6:48 PM EST) -- Consumer, patient and public health groups on Wednesday urged the U.S. Food and Drug Administration to yank its approval of Aptus Endosystems Inc.'s suturing system used to repair aortic aneurysms, claiming the agency skipped testing that determines if life-saving medical devices are safe and effective....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!